Altogether, our study not only identified a new biological role of CTSS in EGFR signalling regulation, but also provided a mechanical rationale to combine a CTSS inhibitor and an EGFR tyrosine kinase inhibitor for treating cancer through EGFR expression in the future. The gene discussed is EGFR; the disease is cancer.